Literature DB >> 24596443

Role of combined embolization and ablation in management of renal masses.

Ronald S Winokur1, Bradley B Pua1, David C Madoff1.   

Abstract

Combination of minimally invasive treatment modalities is being increasingly utilized to improve local tumor control and overall survival. In the liver, the combination of embolization and ablation results in equivalent overall survival and intrahepatic disease progression as surgical resection for lesions smaller than 7 cm. Ablation alone for small renal masses up to 4 cm results in excellent local tumor control and lack of residual enhancement to suggest viable tumor. A small number of studies have been performed combining embolization and ablation, which result in high rates of local tumor control for tumors smaller than 5 cm. Based on this small cohort, combined embolization and ablation may be most indicated for central or mixed tumors where ablation alone suffers from the greatest degree of "heat sink" effect. This article reviews the theory, methods, and outcomes of combining percutaneous ablative and embolic modalities in the treatment of renal masses.

Entities:  

Keywords:  ablation; combination therapy; embolization; interventional radiology; kidney cancer; renal cancer

Year:  2014        PMID: 24596443      PMCID: PMC3930653          DOI: 10.1055/s-0033-1363846

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  22 in total

Review 1.  Nephron sparing surgery for renal tumors: indications, techniques and outcomes.

Authors:  R G Uzzo; A C Novick
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

2.  Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?

Authors:  S N Goldberg; P F Hahn; K K Tanabe; P R Mueller; W Schima; C A Athanasoulis; C C Compton; L Solbiati; G S Gazelle
Journal:  J Vasc Interv Radiol       Date:  1998 Jan-Feb       Impact factor: 3.464

3.  Superselective particle embolization enhances efficacy of radiofrequency ablation: effects of particle size and sequence of action.

Authors:  Toshihiro Tanaka; Peter Isfort; Till Braunschweig; Saskia Westphal; Anna Woitok; Tobias Penzkofer; Philipp Bruners; Kimihiko Kichikawa; Thomas Schmitz-Rode; Andreas H Mahnken
Journal:  Cardiovasc Intervent Radiol       Date:  2012-10-17       Impact factor: 2.740

4.  Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma.

Authors:  H Zielinski; S Szmigielski; Z Petrovich
Journal:  Am J Clin Oncol       Date:  2000-02       Impact factor: 2.339

5.  Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.

Authors:  Timothy W I Clark; Bruce Malkowicz; S William Stavropoulos; Richard Sanchez; Michael C Soulen; Maxim Itkin; Aalpen Patel; Jeffrey I Mondschein; A J Wein
Journal:  J Vasc Interv Radiol       Date:  2006-03       Impact factor: 3.464

6.  Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.

Authors:  Debra A Gervais; Francis J McGovern; Ronald S Arellano; W Scott McDougal; Peter R Mueller
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

7.  Life-threatening hematuria requiring transcatheter embolization following radiofrequency ablation of renal cell carcinoma.

Authors:  H Roach; T Whittlestone; M P Callaway
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Jul-Aug       Impact factor: 2.740

Review 8.  Renal artery embolization: clinical indications and experience from over 100 cases.

Authors:  Michael J Schwartz; Eric B Smith; David W Trost; E Darracott Vaughan
Journal:  BJU Int       Date:  2006-12-13       Impact factor: 5.588

9.  Treatment of renal cancer patients by transcatheter embolization and its effects on lymphocyte proliferative responses.

Authors:  H Nakano; H Nihira; T Toge
Journal:  J Urol       Date:  1983-07       Impact factor: 7.450

10.  Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.

Authors:  Kiminobu Arima; Kouichirou Yamakado; Hiroyuki Kinbara; Atsuhiro Nakatsuka; Kan Takeda; Yoshiki Sugimura
Journal:  Int J Urol       Date:  2007-07       Impact factor: 3.369

View more
  5 in total

Review 1.  Role of Angio-Embolization for Renal Cell Carcinoma.

Authors:  Andrew J Gunn; Anand R Patel; Soroush Rais-Bahrami
Journal:  Curr Urol Rep       Date:  2018-08-08       Impact factor: 3.092

Review 2.  Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes.

Authors:  Nicholas Kavoussi; Noah Canvasser; Jeffrey Caddedu
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

Review 3.  Renal Embolization: Current Recommendations and Rationale for Clinical Practice.

Authors:  Raja S Ramaswamy; Olaguoke Akinwande; Tatulya Tiwari
Journal:  Curr Urol Rep       Date:  2018-02-05       Impact factor: 3.092

4.  Trans-Arterial Embolization of Renal Cell Carcinoma prior to Percutaneous Ablation: Technical Aspects, Institutional Experience, and Brief Review of the Literature.

Authors:  Andrew J Gunn; Benjamin J Mullenbach; May M Poundstone; Jennifer B Gordetsky; Edgar S Underwood; Soroush Rais-Bahrami
Journal:  Curr Urol       Date:  2018-06-30

5.  Transarterial embolization of renal cell carcinoma as an adjunctive therapy prior to cryoablation: a propensity score matching analysis.

Authors:  Andrew J Gunn; Benjamin J Mullenbach; May M Poundstone; Jennifer B Gordetsky; Edgar S Underwood; Soroush Rais-Bahrami
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.